Rubidium-82: Clinical Trials

2 trials of Rubidium-82, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 not yet recruiting, 1 recruiting. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Not yet recruiting 1, Recruiting 1

Follow Rubidium-82: new trials by email Literature Review of Rubidium-82 trials Research Report on Rubidium-82

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Dynamic 82-Rb Positron Emission Tomography (PET) for the Grading of KIDney Carcinoma
82-Rb injection - Renal Cell Carcinoma
Phase 2Not yet recruitingAssistance Publique - Hôpitaux de Paris502026-01-012026-01-16
18F-mFBG Imaging for Myocardial Sympathetic Innervation
18F-metaFluorobenzylguanidine, Rubidium-82 - Heart Failure, Ischemic Cardiomyopathy
Phase 2RecruitingInnervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC)202025-11-052026-11-17

Conditions studied

Carcinoma, Renal Cell (1)  ·  Heart Failure (1)  ·  Neovascularization, Pathologic (1)

Sponsors

Assistance Publique - Hôpitaux de Paris (1)  ·  Innervate Radiopharmaceuticals LLC (Formerly: Illumina Radiopharmaceuticals LLC) (1)

Countries

France (1)  ·  United States (1)

Top investigators

K. Lance Gould, MD (1)